The Study
From June 1998 through November 1999, a total of 3,848 children and adults seeking treatment for debilitating diarrheal disease were identified from eight hospital sites in Medan, North Sumatra; Padang, West Sumatra; Batam, Riau Island; Jakarta, Java Island; Denpasar, Bali (two hospitals); Pontianak, West Kalimantan; and Makassar, South Sulawesi. Rectal swabs were obtained from patients in the study before antibiotic therapy was administered. Specimens were placed in Cary-Blair transport medium, Dispatches held at 4°C, and sent on wet ice within 2 to 4 days after collection to the U.S. Naval Medical Research Unit No. 2, Jakarta. Bacteriologic evaluation was performed by standard culture method (10) . Species was confirmed by using API 20E (Biomerieux, Marcy l'Etoile, France) and slide agglutination with specific Shigella antisera (Difco Laboratories, Detroit, MI). Antibiotic susceptibility testing was accomplished by the disk-diffusion method (11) .
Overall, bacterial isolates of Shigella spp. were identified in 180 (5%) of 3,848 rectal swabs. The proportional contribution of S. flexneri, S. sonnei, and S. dysenteriae among shigellosis cases was 80%, 12%, and 8%, respectively. No S. boydii was detected. The percentage of representation among the three species did not vary substantially by geographic location. Notable was the reemergence of S. dysenteriae in Bali, West Kalimantan, and Batam, as well as in Jakarta after a hiatus of >15 years (Table) . The proportional distribution of S. flexneri, S. sonnei, and S. dysenteriae for the 5-to 12-year-old and >12-year-old groups was similar. There appeared to be no consistency in the seasonal distribution patterns of Shigella spp. (Figure) . S. flexneri was the most frequently isolated organism, followed by S. sonnei and S. dysenteriae.
Other enteric pathogens isolated were Salmonella spp. (95, 2.5%), Vibrio cholerae (80, 2.1%), V. parahaemolyticus (38, 1%), V. cholerae non-O1 (9, 0.2%), and Campylobacter spp. (27, 0.7%). Enterotoxigenic Escherichia coli were detected in 225 (18.1%) of 1,240 specimens tested by the GM1 enzyme-linked immunoassay (12) . Of the 541 specimens examined for rotavirus in the age groups < 5 years, 191 (35.3%) were positive. Tests to detect parasites showed Ascaris lumbricoides in 8 (2%), Blastocystis hominis in 23 (5.6%), Giardia lamblia in 3 (0.7%), and Endolimax nana in 2 (0.5%) of 407 stool specimens examined.
Clinical presentations associated with non-S. dysenteriae included abdominal cramping (79%), vomiting (56%), and fever (48%); for S. dysenteriae, percentages of the same symptoms were 100%, 64%, and 27%, respectively. Stool samples from patients with S. flexneri, S. sonnei, and S. dysenteriae were principally characterized by mucus in the absence of blood (45%) or mucus and visible blood (27%).
Overall, antibiotic susceptibility patterns showed greater resistance to ampicillin, trimethoprim-sulfamethoxazole, chloramphenicol, and tetracycline for S. flexneri (85%, 59%, 82%, and 98%, respectively, from examination of 144 isolates) and S. sonnei (32%, 79%, 37%, and 100%, respectively, from examination of 22 isolates), than for S. dysenteriae (36%, 43%, 7%, and 29%, respectively, from examination of 14 isolates). There was no evidence of resistance to ceftriaxone, norfloxacin, ciprofloxacin, or nalidixic acid, regardless of Shigella species. Antimicrobial resistance was only apparent among isolates obtained from Jakarta, Bali, and Pontianak.
Conclusions
Our study showed that a substantial proportion (5%) of acute, debilitating diarrheal illness throughout Indonesia can be ascribed to shigellosis; moreover, S. dysenteriae was documented from various geographic locations. Both findings suggest that greater attention should be paid to highlighting the endemic and epidemic community impact of this pathogen and that laboratory detection capabilities need to be enhanced. Recognition of emerging and or reemerging disease pathogens requires reliable baseline and ongoing surveillance data.
Shifting patterns of antimicrobial-drug resistance, particularly in much of the developing world, are generally a function of overuse and (8) , 72% of Shigella spp. were resistant to tetracycline, but less than 30% were resistant to chloramphenicol, trimethroprimsulfamethoxazole, or ampicillin. Previous studies from Bangladesh and Tanzania (13, 6) showed that almost all tested isolates were resistant to the antibiotics used for treatment. Similar antimicrobial resistance profiles for Shigella spp. were reported from Thailand (14) , where high resistance to ampicillin, trimethroprimsulfamethoxazole, chloramphenicol, and tetracycline was documented. The reemergence of S. dysenteriae from several locations in Indonesia should prove cause for concern to health officials, particularly in monitoring acute, debilitating diarrheal outbreaks. The epidemic potential attributed to S. dysenteriae, as documented in Central America, Asia, and Africa, in conjunction with notably high death rates, warrants close attention to this reemerging pathogen in Indonesia (13, 15, 16) .
